Why would Co­hen reach out to No­var­tis, but not Roche?; WuXi Bi­o­log­ics blue­prints big R&D/man­u­fac­tur­ing com­plex

→ So why would Trump at­tor­ney Michael Co­hen reach out to sell his ser­vices to No­var­tis, but ig­nore the big Basel ri­val Roche? “I have …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.